Powder: -20°C for 3 years | In solvent: -80°C for 1 year
hMAO-B/MB-COMT-IN-1 is a dual MAO-B/MB-COMT inhibitor with IC50s of 2.5 μΜ for hMAO-B and 3.84 μΜ for MB-COMT. hMAO-B/MB-COMT-IN-1 protects cells from oxidative damage that can be used in neurodegeneration disease research, for example, Parkinson’s Disease (PD) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | hMAO-B/MB-COMT-IN-1 is a dual MAO-B/MB-COMT inhibitor with IC50s of 2.5 μΜ for hMAO-B and 3.84 μΜ for MB-COMT. hMAO-B/MB-COMT-IN-1 protects cells from oxidative damage that can be used in neurodegeneration disease research, for example, Parkinson’s Disease (PD) [1]. |
In vitro | hMAO-B/MB-COMT-IN-1 (compound 3, 50 μM, 24h) reduces resazurin reduction and induces lysosomal toxicity through reactive oxygen species (ROS) production in differentiated SH-SY5Y cells, as evidenced in studies [1]. At a lower concentration (10 μM, 30 min), it exhibits notable cytoprotective properties against t-BHP in these cells [1]. Furthermore, it is anticipated to traverse the blood-brain barrier (BBB) via passive diffusion, as suggested by results from the parallel artificial membrane permeability assay (PAMPA)-BBB kit [1]. |
Molecular Weight | 273.33 |
Formula | C16H19NO3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
hMAO-B/MB-COMT-IN-1 inhibitor inhibit